Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis.
Yoshiya TanakaTsutomu TakeuchiDaisuke KatoYuichiro KanekoMusashi FukudaDaisuke MiyatakePublished in: Modern rheumatology (2021)
Peficitinib was efficacious in adult Asian RA patients of all ages. Age, but not estimated glomerular filtration rate, was associated with serious infections and herpes zoster-related disease, demonstrating the importance of an appropriate RA treatment strategy in older patients.